Showing results (111-120 of 155) with videos related to
Sort By:
Pageof 16
The British Journal of Dermatology|August 3, 2006
Minimizing adverse side-effects of oral bexarotene in cutaneous T-cell lymphoma: an expert opinionC Assaf, M Bagot, R Dummer, et al.Human Molecular Genetics|July 1, 1994
Localization of the gene whose mutations underlie Hailey-Hailey disease to chromosome 3qS Ikeda, E A Welsh, A M Peluso, et al.Archives of Dermatology|May 18, 2001
Phase 2 and 3 clinical trial of oral bexarotene (Targretin capsules) for the treatment of refractory or persistent early-stage cutaneous T-cell lymphomaM Duvic, A G Martin, Y Kim, et al.The British Journal of Dermatology|June 8, 2007
The optimal use of bexarotene in cutaneous T-cell lymphomaR Gniadecki, C Assaf, M Bagot, et al.Journal of the American Academy of Dermatology|June 1, 1996
Combined modality therapy for cutaneous T-cell lymphomaM Duvic, N A Lemak, J R Redman, et al.Journal of the American Academy of Dermatology|January 28, 1999
Alterations in HIV expression in AIDS patients with psoriasis or pruritus treated with phototherapyJ Breuer-McHam, G Marshall, A Adu-Oppong, et al.Pediatric Dermatology|June 1, 1989
Kindler syndrome: report of two cases and review of the literatureA B Forman, J S Prendiville, N B Esterly, et al.The Journal of Investigative Dermatology|July 1, 1997
Tazarotene-induced gene 2 (TIG2), a novel retinoid-responsive gene in skinS Nagpal, S Patel, H Jacobe, et al.Genomics|October 1, 1992
The gene for a novel epidermal antigen maps near the neurofibromatosis 1 geneL M Kayes, W T Schroeder, D A Marchuk, et al.Genomics|May 20, 1995
Epidermal surface antigen (MS17S1) is highly conserved between mouse and humanY J Cho, D Chema, J J Moskow, et al.Pageof 16